117 related articles for article (PubMed ID: 15384976)
1. Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas.
Drénou B; Tilanus M; Semana G; Alizadeh M; Birebent B; Grosset JM; Dias P; van Wichen D; Arts Y; De Santis D; Fauchet R; Amiot L
Br J Haematol; 2004 Oct; 127(1):40-9. PubMed ID: 15384976
[TBL] [Abstract][Full Text] [Related]
2. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
[TBL] [Abstract][Full Text] [Related]
3. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
[TBL] [Abstract][Full Text] [Related]
6. Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.
Jordanova ES; Riemersma SA; Philippo K; Giphart-Gassler M; Schuuring E; Kluin PM
Genes Chromosomes Cancer; 2002 Sep; 35(1):38-48. PubMed ID: 12203788
[TBL] [Abstract][Full Text] [Related]
7. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
8. Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas.
Nakamura M; Kishi M; Sakaki T; Hashimoto H; Nakase H; Shimada K; Ishida E; Konishi N
Cancer Res; 2003 Feb; 63(4):737-41. PubMed ID: 12591717
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
Ryschich E; Cebotari O; Fabian OV; Autschbach F; Kleeff J; Friess H; Bierhaus A; Büchler MW; Schmidt J
Tissue Antigens; 2004 Dec; 64(6):696-702. PubMed ID: 15546343
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
[TBL] [Abstract][Full Text] [Related]
13. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
14. Analysis of human lymphocyte antigen class I expression in gastric cancer by reverse transcriptase-polymerase chain reaction.
Dutta N; Majumder D; Gupta A; Mazumder DN; Banerjee S
Hum Immunol; 2005 Feb; 66(2):164-9. PubMed ID: 15695002
[TBL] [Abstract][Full Text] [Related]
15. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
16. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
[TBL] [Abstract][Full Text] [Related]
17. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
[TBL] [Abstract][Full Text] [Related]
18. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
19. Evidence for Induced Expression of HLA Class II on Human Islets: Possible Mechanism for HLA Sensitization in Transplant Recipients.
Jackson AM; Connolly JE; Matsumoto S; Noguchi H; Onaca N; Levy MF; Naziruddin B
Transplantation; 2009 Feb; 87(4):500-6. PubMed ID: 19307785
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric sorting of paraffin-embedded tumor tissues considerably improves molecular genetic analysis.
Jordanova ES; Corver WE; Vonk MJ; Leers MP; Riemersma SA; Schuuring E; Kluin PM
Am J Clin Pathol; 2003 Sep; 120(3):327-34. PubMed ID: 14502796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]